189 related articles for article (PubMed ID: 34672926)
61. Screening Tool for Anxiety Disorders: Development and Validation of the Korean Anxiety Screening Assessment.
Kim Y; Park Y; Cho G; Park K; Kim SH; Baik SY; Kim CL; Jung S; Lee WH; Choi Y; Lee SH; Choi KH
Psychiatry Investig; 2018 Nov; 15(11):1053-1063. PubMed ID: 30481992
[TBL] [Abstract][Full Text] [Related]
62. Psychometric properties of the Intolerance of Uncertainty Scale-12 in generalized anxiety disorder: Assessment of factor structure, measurement properties and clinical utility.
Wilson EJ; Stapinski L; Dueber DM; Rapee RM; Burton AL; Abbott MJ
J Anxiety Disord; 2020 Dec; 76():102309. PubMed ID: 33002756
[TBL] [Abstract][Full Text] [Related]
63. Health-related quality of life in Iranian adolescents: a psychometric evaluation of the self-report form of the PedsQL 4.0 and an investigation of gender and age differences.
Hadianfard H; Kiani B; Azizzadeh Herozi M; Mohajelin F; Mitchell JT
Health Qual Life Outcomes; 2021 Mar; 19(1):108. PubMed ID: 33771186
[TBL] [Abstract][Full Text] [Related]
64. Ultra-short screening instruments for major depressive episode and generalized anxiety disorder in epilepsy: The NDDIE-2 and the GAD-SI.
Micoulaud-Franchi JA; Bartolomei F; McGonigal A
J Affect Disord; 2017 Mar; 210():237-240. PubMed ID: 28064112
[TBL] [Abstract][Full Text] [Related]
65. The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation.
Mossman SA; Luft MJ; Schroeder HK; Varney ST; Fleck DE; Barzman DH; Gilman R; DelBello MP; Strawn JR
Ann Clin Psychiatry; 2017 Nov; 29(4):227-234A. PubMed ID: 29069107
[TBL] [Abstract][Full Text] [Related]
66. Evaluating the GAD-2 to screen for post-stroke anxiety on an acute stroke unit.
McCrory M; Murphy DF; Morris RC; Noad RF
Neuropsychol Rehabil; 2023 Apr; 33(3):480-496. PubMed ID: 35152850
[TBL] [Abstract][Full Text] [Related]
67. Psychometric properties of the CES-D-10 in a psychiatric sample.
Björgvinsson T; Kertz SJ; Bigda-Peyton JS; McCoy KL; Aderka IM
Assessment; 2013 Aug; 20(4):429-36. PubMed ID: 23513010
[TBL] [Abstract][Full Text] [Related]
68. Psychometric properties and diagnostic accuracy of the short form of the geriatric anxiety scale (GAS-10).
Carlucci L; Balestrieri M; Maso E; Marini A; Conte N; Balsamo M
BMC Geriatr; 2021 Jun; 21(1):401. PubMed ID: 34193082
[TBL] [Abstract][Full Text] [Related]
69. Adaptation and initial validation of the Patient Health Questionnaire - 9 (PHQ-9) and the Generalized Anxiety Disorder - 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample.
Sawaya H; Atoui M; Hamadeh A; Zeinoun P; Nahas Z
Psychiatry Res; 2016 May; 239():245-52. PubMed ID: 27031595
[TBL] [Abstract][Full Text] [Related]
70. Development and validation of the Generalized Anxiety Disorder Inventory (GADI).
Argyropoulos SV; Ploubidis GB; Wright TS; Palm ME; Hood SD; Nash JR; Taylor AC; Forshall SW; Anderson IM; Nutt DJ; Potokar JP
J Psychopharmacol; 2007 Mar; 21(2):145-52. PubMed ID: 17329293
[TBL] [Abstract][Full Text] [Related]
71. Validity of the PROMIS depression and anxiety common metrics in an online sample of Australian adults.
Sunderland M; Batterham P; Calear A; Carragher N
Qual Life Res; 2018 Sep; 27(9):2453-2458. PubMed ID: 29872956
[TBL] [Abstract][Full Text] [Related]
72. Factor structure and construct validity of the Generalized Anxiety Disorder 7-item (GAD-7) among Portuguese college students.
Bártolo A; Monteiro S; Pereira A
Cad Saude Publica; 2017 Sep; 33(9):e00212716. PubMed ID: 28977285
[TBL] [Abstract][Full Text] [Related]
73. A psychometric analysis of the Revised Child Anxiety and Depression Scales--parent version in a school sample.
Ebesutani C; Chorpita BF; Higa-McMillan CK; Nakamura BJ; Regan J; Lynch RE
J Abnorm Child Psychol; 2011 Feb; 39(2):173-85. PubMed ID: 20878460
[TBL] [Abstract][Full Text] [Related]
74. The psychometric properties of the Depression Anxiety Stress Scale-21 (DASS-21) Bangla version.
Ahmed O; Faisal RA; Alim SMAHM; Sharker T; Hiramoni FA
Acta Psychol (Amst); 2022 Mar; 223():103509. PubMed ID: 35065529
[TBL] [Abstract][Full Text] [Related]
75. Screening for depression in pregnant women from Côte d׳Ivoire and Ghana: Psychometric properties of the Patient Health Questionnaire-9.
Barthel D; Barkmann C; Ehrhardt S; Schoppen S; Bindt C;
J Affect Disord; 2015 Nov; 187():232-40. PubMed ID: 26343851
[TBL] [Abstract][Full Text] [Related]
76. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
[TBL] [Abstract][Full Text] [Related]
77. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care.
Gaynes BN; DeVeaugh-Geiss J; Weir S; Gu H; MacPherson C; Schulberg HC; Culpepper L; Rubinow DR
Ann Fam Med; 2010; 8(2):160-9. PubMed ID: 20212303
[TBL] [Abstract][Full Text] [Related]
78. Anxiety and depression screening for youth in a primary care population.
Katon W; Russo J; Richardson L; McCauley E; Lozano P
Ambul Pediatr; 2008; 8(3):182-8. PubMed ID: 18501865
[TBL] [Abstract][Full Text] [Related]
79. Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment.
Delgadillo J; Payne S; Gilbody S; Godfrey C; Gore S; Jessop D; Dale V
Drug Alcohol Depend; 2012 Sep; 125(1-2):37-42. PubMed ID: 22480667
[TBL] [Abstract][Full Text] [Related]
80. Convergent and discriminant validity and reliability of the pediatric anxiety rating scale in youth with autism spectrum disorders.
Storch EA; Wood JJ; Ehrenreich-May J; Jones AM; Park JM; Lewin AB; Murphy TK
J Autism Dev Disord; 2012 Nov; 42(11):2374-82. PubMed ID: 22395820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
